L’Oreal’s Microbiome Explorations Lead To Micreos Deal For Next-Gen Antibacterial

“We expect this partnership to be groundbreaking,” says Mark Offerhaus, CEO of Micreos, which will provide L’Oreal with its proprietary endolysin, which selectively destroys microorganisms associated with skin problems while leaving beneficial bacteria intact.